Lykos takes an­oth­er hit as ICER lays out 'in­suf­fi­cien­t' ev­i­dence for MD­MA-based treat­ment

11 months ago
R&D
Pharma

House pan­el ad­vances bill to al­low Medicare to cov­er obe­si­ty drugs

11 months ago
Pharma
FDA+

What Co­herus' $40M sale of its Hu­mi­ra biosim­i­lar says about the crowd­ed mar­ket

11 months ago
Deals
Pharma

Supreme Court nar­row­ly re­jects Pur­due bank­rupt­cy plan, says it gives Sack­lers too much pro­tec­tion

11 months ago
Pharma
Law

To tack­le a dead­ly brain dis­ease, sci­en­tists de­vise small but charm­ing epi­ge­net­ic edit­ing tool

11 months ago
R&D
Discovery

Grail pi­o­neered mul­ti-can­cer tests. But the com­pa­ny’s rough pub­lic de­but shows the in­dus­try could be in trou­ble

11 months ago
Pharma
Diagnostics

GSK’s man­u­fac­tur­ing sites in Sin­ga­pore will use 100% re­new­able en­er­gy by 2025 

11 months ago
Manufacturing

SK Bio­science takes ma­jor­i­ty stake in CD­MO for $244M; Ex-Lon­za CEO joins Cy­ti­va

11 months ago
Manufacturing

Bio­gen is pur­su­ing more deal­mak­ing this year, with plans to spend up to $8B

11 months ago
Deals
R&D

Re­cur­sion’s $200M of­fer­ing; Sanofi in­vests $40M in Vig­il Neu­ro­science

11 months ago
News Briefing

Ab­b­Vie buys Third Rock­'s Cel­sius for $250M to ex­pand IBD pipeline

11 months ago
Deals
Pharma

Si­lence re­ports Phase 1 da­ta from rare blood dis­or­der tri­al

11 months ago
R&D

Q&A: Ver­tex’s pain re­search chief on mov­ing be­yond opi­oids, AI and how phar­ma ac­qui­si­tions thrive or fail

11 months ago
People
R&D

One Med­ical CEO-turned-VC wants star­tups that are 'dis­rup­tive from with­in the ecosys­tem'

11 months ago
Financing
Startups

Ex­clu­sive: To de­vel­op bet­ter cell ther­a­pies for sol­id tu­mors, a new start­up plans to test hun­dreds of them at once

11 months ago
Financing
Startups

Longevi­ty in­vestors look to add $200M to the ta­ble with new growth fund

11 months ago
Financing
Startups

Maze spins its ALS an­ti­sense pro­gram in­to a se­cre­tive new com­pa­ny

11 months ago
Startups
Deals

Eu­roAPI over­haul comes in­to fo­cus with plans to cut 550 staffers and di­vest two fa­cil­i­ties 

11 months ago
Manufacturing

Ab­b­Vie and Gen­mab score ac­cel­er­at­ed fol­lic­u­lar lym­phoma nod for Ep­kin­ly 

11 months ago
Pharma
FDA+

FDA re­jects Dai­ichi Sanky­o's HER3 ADC, a blow to quick ap­proval plans for Mer­ck part­ner­ship

11 months ago
R&D
Pharma

Dig­i­tal health fund­ing flat­tens out, Pitch­Book re­port shows

11 months ago
Health Tech

FDA ap­proves new COPD drug from Verona Phar­ma

11 months ago
Pharma
FDA+

Up­dat­ed: CDC ex­pands RSV vac­cine rec­om­men­da­tions, name­ly for adults 75 and old­er

11 months ago
Pharma
FDA+

Ha­le­on to sell nico­tine re­place­ment ther­a­py busi­ness to Dr. Red­dy’s for $630M

11 months ago
Deals
Pharma
First page Previous page 137138139140141142143 Next page Last page
A service from the Financial Times